Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;84(3):418-467.
doi: 10.1016/j.jinf.2021.11.001. Epub 2021 Nov 6.

Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?

Affiliations

Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?

Justus J Bürgi et al. J Infect. 2022 Mar.

Abstract

Image, graphical abstract

Keywords: Antibodies; COVID-19; IgA; SARS-CoV-2; Serology.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no competing interests.

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
Overall dynamic changes in anti-SARS-CoV-2 antibody levels (IgG and IgA) over time. Results were grouped according to the time after positive PCR diagnosis: 2–6 weeks (n = 408, 21.3%), 7–11 weeks (n = 690, 36.0%), 12–16 weeks (n = 257, 13.4%), 17–21 weeks (n = 73, 3.8%), 22–26 weeks (n = 143, 7.5%), 27–31 weeks (n = 156, 8.1%), 32–37 weeks (n = 72, 3.8%) and 52–57 weeks (n = 119, 6.2%). Horizontal bold lines indicate median values; boxes indicate quartiles 1 and 3; whiskers indicate 1.5 * IQR confidence intervals; dotted magenta line indicate optical density (OD) ratio at 1.1 (positive cut-off); dotted black line indicate OD ratio at 0.8 for anti-S antibodies, 0.9 for anti-N IgG (values below are considered negative); gray shaded region in-between OD ratio 0.8/0.9–1.1 contains borderline results. Black line represents all individuals, independent of the number of study courses. Yellow dots and line represent individuals performing a singular study course (1–5 longitudinal blood draws) and blue dots and line represent individuals with multiple study courses (1–15 longitudinal blood draws). Each point represents a single measurement. (A) anti-spike (S) IgG; (B) anti-S IgA; (C) anti-nucleocapsid (N) IgG; (D) Gender and age specific dynamic changes in anti-S IgG antibody levels over time. 1 = female individuals with age higher than 54 years; 2 = female individuals with age lower than 54 years; 3 = male individuals with age higher than 54 years; 4 = male individuals with age lower than 54 years.
Fig 2
Fig. 2
Longitudinal courses of individual anti-SARS-CoV-2 antibody levels (IgG and IgA) over time. Individual longitudinal anti-spike IgG and anti-spike IgA courses were analyzed utilizing robust regression (period week 17–57) using an MM estimator, which is an M-estimation with Turkey's biweight initialized by a specific S-estimator. The corresponding slopes were categorized according to the following properties of their individual course: Declining antibody concentrations were defined by a negative slope value (slope < 0 OD ratio/week); increasing antibody concentrations were defined by a positive slope value (slope > 0 OD ratio/week). Blue line represents an illustrative line indicating the averaged present slope calculated by the robust regression of data from week 17 to 57; dotted magenta line indicate optical density (OD) ratio at 1.1 (positive cut-off); dotted black line indicate OD ratio of 0.8 (values below are considered negative); gray shaded region in-between OD ratio 0.8–1.1 contains borderline results. Each point represents a single measurement. (A) anti-spike IgG (n = 47, 89%) and IgA (n = 19, 36%) antibody levels with declining tendency. (B) anti-spike IgG (n = 6, 11%) and IgA (n = 34, 64%) antibody levels with increasing tendency.

References

    1. Korte W., Buljan M., Rösslein M., Wick P., Golubov V., Jentsch J., et al. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. J Infect. 2021;82(1):e11–ee4. JanPubMed PMID: 32853597. Pubmed Central PMCID: PMC7445467. Epub 2020/08/28. - PMC - PubMed
    1. Manisty C., Treibel T.A., Jensen M., Semper A., Joy G., Gupta R.K., et al. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection. EBioMedicine. 2021;65 MarPubMed PMID: 33662833. Pubmed Central PMCID: PMC7920816. Epub 2021/03/05. eng. - PMC - PubMed
    1. Wickham M.A.H., Bryan J., Chang W., McGowan L.D.A., François R., Grolemund G., et al. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686.
    1. Laing E.D., Epsi N.J., Richard S.A., Samuels E.C., Wang W., Vassell R., et al. medRxiv; 2021. SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity. 2021.04.27.21256207.
    1. Amanna I.J., Slifka M.K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev. 2010;236(1):125–138. JulPubMed PMID: 20636813. Pubmed Central PMCID: PMC7165522. Epub 2010/07/20. eng. - PMC - PubMed

Publication types